ECLS supported in toxicologic cardiogenic shock based on observational outcomes
Often cited as Class IIa recommendation in consensus guidance
Special Populations
Pregnancy
Pregnancy considerations
Maternal stabilization priority
Placental perfusion depends on maternal perfusion
Early vasopressor support when needed
Medication considerations
High-dose insulin use acceptable with close glucose monitoring
Glucagon acceptable for maternal rescue
Obstetric coordination
Fetal monitoring when viable gestation
Delivery planning if maternal arrest or peri-arrest
Geriatric
Older adult considerations
Higher baseline conduction disease prevalence
Early pacing consideration
Lower reserve for hypotension
Polypharmacy risk
Co-ingestion of other nodal blockers
Interaction with antiarrhythmics
Renal impairment common
Prolonged toxicity with renally cleared beta-blockers
Longer observation duration
Pediatrics
Pediatric considerations
Weight-based dosing accuracy
High-dose insulin dosing by kg
Calcium dosing by kg
Early hypoglycemia risk
Beta-blocker ingestion in toddlers
Frequent glucose checks
Unintentional ingestion patterns
Single tablet significant for certain agents
Child protective evaluation as appropriate
Background
Epidemiology
Exposure patterns
Common agents
Metoprolol
Propranolol
Verapamil
Diltiazem
Amlodipine
High-risk formulations
Sustained-release verapamil and diltiazem
Large amlodipine ingestions with delayed shock
Morbidity drivers
Refractory hypotension
Bradyarrhythmia and arrest
Pathophysiology
Beta-blocker mechanisms
Decreased chronotropy
Sinus bradycardia
AV block
Decreased inotropy
Cardiogenic shock
Pulmonary edema
Membrane-stabilizing activity
QRS widening
Ventricular dysrhythmia
CNS penetration
Seizures with propranolol
Coma in severe overdose
Calcium channel blocker mechanisms
L-type calcium channel blockade
Reduced contractility
AV nodal depression
Vascular smooth muscle relaxation
Vasodilatory shock with dihydropyridines
Reflex tachycardia sometimes absent in overdose
Metabolic effects
Reduced insulin secretion
Hyperglycemia and lactic acidosis
Therapeutic Considerations
Rationale for high-dose insulin
Inotropy improvement via myocardial carbohydrate utilization
Enhanced intracellular glucose delivery
Benefit in CCB-induced myocardial depression
Rationale for calcium
Overcoming competitive calcium channel blockade
Improved contractility and conduction
Rationale for glucagon
Increased intracellular cAMP independent of beta-receptors
Transient improvement in heart rate and contractility
Guideline style recommendations
Early poison center involvement supported by toxicology societies
Expert consensus
Resource coordination for antidotes and ECMO
High-dose insulin favored for refractory shock in CCB toxicity
Consensus Class IIa style recommendation
Earlier initiation associated with improved response
Patient Discharge Instructions
Copy discharge instructions
Discharge counseling for mild exposure
Observation completed with stable vitals and normal ECG
No dizziness
No syncope
Return to ED immediately for red flags
Fainting or near-fainting
New chest pain
Trouble breathing
Severe weakness or confusion
Persistent vomiting
Medication safety
Keep pills in child-resistant containers
Store medications locked and out of reach
Follow-up
Primary care follow-up within 24-72 hours
Poison center number provided if available locally
References
Clinical guidelines and consensus
Toxicology society guidance
American College of Medical Toxicology guidance on high-dose insulin therapy
American Academy of Clinical Toxicology position statements on lipid emulsion therapy
Resuscitation guidance
American Heart Association scientific statements on toxicologic cardiac arrest and antidotes
Advanced cardiac life support bradycardia and pacing algorithms
Evidence-based sources
Key evidence base
Observational studies supporting high-dose insulin in calcium channel blocker overdose
Case series supporting glucagon responsiveness in beta-blocker overdose
Registry and cohort data supporting VA-ECMO for poison-induced cardiogenic shock
Toxicology textbooks and poison center protocols for dosing standards
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.